Transition Therapeutics, Inc. (TTHI) Narrows Q1 Loss
Tweet
Share
E-mailGet Alerts TTHI Hot Sheet
Join SI Premium – FREE
Transition Therapeutics, Inc. (NASDAQ: TTHI) reported Q1 EPS of ($0.12), versus ($0.15) reported last year.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Neumora Therapeutics, Inc. (NMRA) Tops Q2 EPS by 4c
- Reading (RDI) Tops Q2 EPS by 4c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
